Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
3(100.0%)
3Total
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06813027Phase 1Active Not Recruiting

Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.

Role: collaborator

NCT06937528Phase 1Recruiting

Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis

Role: collaborator

NCT06825884Phase 1Active Not Recruiting

Use of Extracellular Vesicles (EV) for Diabetic Foot Ulcers

Role: collaborator

All 3 trials loaded